Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-11 | New | $275,000 | $275,000 | Equity and Debt | 06b | SEC link |
| 2023-07-13 | New | Yet to Sell | $0 | Debt Only | 06b | SEC link |
| 2020-08-04 | New | $2,000,000 | $2,000,000 | Equity and Debt | 06b | SEC link |
| 2019-05-07 | New | $600,000 | $600,000 | Equity and Debt | 06b | SEC link |
| 2019-05-07 | New | $27,000,000 | $27,000,000 | Equity Only | 06b | SEC link |
| 2018-04-25 | New | $2,925,000 | $2,925,000 | Equity Only | 06b | SEC link |
| 2010-03-26 | New | $7,500,000 | $7,500,000 | Equity Only | 06 | SEC link |
| 2008-11-04 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| David J. Chaplin | Director, Executive |
| Seymour Fein | Executive |
| Roy H. Fickling | Director |
| Mark Kessel | Director |
| Peter J. Langecker | Executive |
| Matthew Loar | Executive |
| Anthony Maida | Executive |
| James B. Murphy | Executive |
| Chuho Park | Executive |
| Chulho Park | Executive |
| Simon C. Pedder | Director |
| Donald R. Reynolds | Director |
| Bobby W. Sandage, Jr. | Director |
| Saran Saund | Executive |
| William Schwieterman | Director |
| Amit Shah | Executive |
| William N. Shiebler | Director |
| Vuong Trieu | Director, Executive |
| Fatih Uckun | Executive |
| Alastair J.J. Wood | Director |